Samsara BioCapital, LLC

CIK 0001744967 · Q2 2026

13F Equity AUM

$1.2B

+18.3% QoQ

Positions

+2 QoQ

AUM Rank

#2,121

Top 24%

Skill Alpha (FF)

-9.0%/yr^ns

No Clear Edge

Rank #8,006 · Top 96%

vs S&P -20.4%/yr (unadj.)

Quarters Tracked

~7 years

Portfolio Concentration

Top 5: 73.0%Top 10: 90.5%Top 20: 98.8%

SRRK31.2%

ALMS14.7%

MLYS13.0%

SEPN8.7%

Unknown5.5%

NGNE4.4%

KLRS4.3%

Unknown3.9%

STRO2.9%

IVA2.0%

Others (14)9.5%

HHI (Herfindahl-Hirschman Index) measures portfolio concentration. Low (<1500) = diversified, Moderate (1500-2500), High (>2500) = concentrated bets.

Sector Allocation

Healthcare88.3%

Unclassified11.7%

Portfolio weight by GICS sector based on latest 13F filing. Sectors below 2% are grouped as “Other.”

Position Sizing

Positions: 24Median: 1.09%Avg: 4.17%

0–0.5%

4(1.1%)

0.5–1%

8(5.8%)

1–3%

4(7.5%)

3–5%

3(12.6%)

5%+

5(73.0%)

Count of positions per weight bucket — (%) = combined portfolio weight

Loading summary cards...

Portfolio Overlap

Shared: 0Unique: 24vs 20 funds

0%Low

Fund positions

Consensus CUSIPs

Jaccard similarity of this fund’s portfolio vs the consensus of top 20 funds by AUM. Low (<15%) = contrarian, Moderate (15-40%), High (>40%) = follows the crowd.

Loading overlap analysis...

Position Changes This Quarter

New4Increased2Decreased5Exited2

New Positions

—5.5%

+2.5M

—1.3%

+556K

ARTV0.8%

+955K

—0.5%

+400K

Increased

RANI0.7%

+1.9M(+22%)

IVA2.0%

+1.1M(+22%)

Decreased

XFOR0.5%

-436,979(-24%)

UPB0.2%

-382,330(-52%)

JBIO1.3%

-232,561(-24%)

KLRS4.3%

-66,906(-1%)

ABVX0.6%

-1,486(-3%)

Exited

ACLX

-60,873

PVLA

-38,432

Quarter-over-quarter changes compared to prior 13F filing. New = first appearance; Exited = no longer held.

Loading position changes...

Holdings

Loading holdings...